Cardiovascular Diseases

Glucosamine Supplement Linked to Lower CVD Risk

A UK prospective cohort study suggested that habitual use of glucosamine supplement to relieve osteoarthritis pain might also be related to lower risks of cardiovascular diseases (CVD) events. The study enrolled 466 039 participants from 2006 to 2010. During a median follow-up of 7 years, there were 10 204 incident CVD events, 3060 CVD deaths, 5745 coronary heart disease events, and 3263 stroke events. After adjustment for age, sex, body mass index, race, lifestyle factors, dietary intakes, drug use, and other supplement use, glucosamine use was associated with a significantly lower risk of total CVD events (hazard ratio 0.85), CVD death (0.78), coronary heart disease (0.82), and stroke (0.91). The findings are in line with several previous studies and suggest that glucosamine might have a preventive role in CVD through anti-inflammatory and mimicking a low carbohydrate diet properties. Source: https://www.bmj.com/

hyangiu

Recent Posts

SGLT2 Inhibitors Tied to Lower Risk in Patients with Diabetes and Cirrhosis

A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…

1 day ago

Lobar and Mixed Cerebral Microbleeds Linked to Increased Dementia Risk

A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…

4 days ago

DASH Diet Best for Long-Term Brain Health

A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…

1 week ago

Intermittent Fasting Shows No Clear Advantage Over Traditional Diets for Weight Loss

A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…

2 weeks ago

Healthy Dietary Patterns Linked to Better Life Expectancy

A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…

3 weeks ago

Statin Adverse Effects Analysis: Separating Signal from Noise

To address uncertainties in statin safety profiles, which are often based on observational data susceptible…

4 weeks ago

This website uses cookies.